मूलभूत आँकड़े
| LEI | 5493003UA6VMND084504 |
| CIK | 1532063 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Express Scripts Holding Co.
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
| July 23, 2019 |
ESRX / Express Scripts Holding Co. S-4/A - - S-4/A As filed with the Securities and Exchange Commission on July 23, 2019 Registration No. |
|
| June 21, 2019 |
[FORM OF] FACE OF EXCHANGE NOTE Exhibit 4.8 [FORM OF] FACE OF EXCHANGE NOTE UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPR |
|
| June 21, 2019 |
[FORM OF] FACE OF EXCHANGE NOTE Exhibit 4.5 [FORM OF] FACE OF EXCHANGE NOTE UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPR |
|
| June 21, 2019 |
[FORM OF] FACE OF EXCHANGE NOTE Exhibit 4.6 [FORM OF] FACE OF EXCHANGE NOTE UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPR |
|
| June 21, 2019 |
Amount of decrease in principal amount of this Global Exhibit 4.11 [FORM OF] FACE OF EXCHANGE NOTE UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REP |
|
| June 21, 2019 |
[FORM OF] FACE OF EXCHANGE NOTE Exhibit 4.14 [FORM OF] FACE OF EXCHANGE NOTE UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REP |
|
| June 21, 2019 |
[FORM OF] FACE OF EXCHANGE NOTE Exhibit 4.9 [FORM OF] FACE OF EXCHANGE NOTE UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPR |
|
| June 21, 2019 |
800 Nicollet Mall Minneapolis, Minnesota Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 31-0841368 I.R.S. Employer Identific |
|
| June 21, 2019 |
ESRX / Express Scripts Holding Co. S-4 - - FORM S-4 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on June 21, 2019 Registration No. |
|
| June 21, 2019 |
[FORM OF] FACE OF EXCHANGE NOTE Exhibit 4.10 [FORM OF] FACE OF EXCHANGE NOTE UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REP |
|
| June 21, 2019 |
CIGNA CORPORATION LETTER OF TRANSMITTAL OFFER TO EXCHANGE Exhibit 99.1 CIGNA CORPORATION LETTER OF TRANSMITTAL OFFER TO EXCHANGE $1,000,000,000 PRINCIPAL AMOUNT OF ITS SENIOR FLOATING RATE NOTES DUE 2020, THE ISSUANCE OF WHICH HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, FOR AN EQUAL PRINCIPAL AMOUNT OF SENIOR FLOATING RATE NOTES DUE 2020 $1,750,000,000 PRINCIPAL AMOUNT OF ITS 3.200% SENIOR NOTES DUE 2020, THE ISSUANCE OF WHICH HAS B |
|
| June 21, 2019 |
Amount of decrease in principal amount of this Global Exhibit 4.12 [FORM OF] FACE OF EXCHANGE NOTE UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REP |
|
| June 21, 2019 |
[FORM OF] FACE OF EXCHANGE NOTE Exhibit 4.13 [FORM OF] FACE OF EXCHANGE NOTE UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REP |
|
| June 21, 2019 |
[FORM OF] FACE OF EXCHANGE NOTE Exhibit 4.7 [FORM OF] FACE OF EXCHANGE NOTE UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPR |
|
| December 31, 2018 |
ESRX / Express Scripts Holding Co. 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-35490 EXPRESS SCRIPTS HOLDING COMPANY, as Issuer and each Subsidiary Gua |
|
| December 20, 2018 |
ESRX / Express Scripts Holding Co. S-8 As filed with the U.S. Securities and Exchange Commission on December 20, 2018 Registration No. 333-211133 Registration No. 333-180507 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-211133 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-180507 EXPRESS SCRIPTS HOLDING COMPANY |
|
| December 20, 2018 |
ESRX / Express Scripts Holding Co. S-8 As filed with the U.S. Securities and Exchange Commission on December 20, 2018 Registration No. 333-211133 Registration No. 333-180507 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-211133 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-180507 EXPRESS SCRIPTS HOLDING COMPANY |
|
| December 20, 2018 |
ESRX / Express Scripts Holding Co. POS AM As filed with the Securities and Exchange Commission on December 20, 2018 Registration No. |
|
| December 20, 2018 |
Exhibit 4.5 EXECUTION VERSION NINTH SUPPLEMENTAL INDENTURE The Ninth Supplemental Indenture, dated as of December 20, 2018 (this “Supplemental Indenture No. 9”), among CIGNA CORPORATION (formerly known as Halfmoon Parent, Inc.) (the “Parent Guarantor”), a corporation organized and existing under the laws of the State of Delaware, EXPRESS SCRIPTS, INC. (the “Company”), a corporation organized and e |
|
| December 20, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): December 20, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of incorporation) ( |
|
| December 20, 2018 |
Exhibit 99.1 Press Release Cigna Completes Combination with Express Scripts, Establishing a Blueprint to Transform the Health Care System · Cigna with Express Scripts to deliver improved affordability, choice, and predictability through flexible, open and connected solutions · Celebrates first day as a combined company by announcing an incremental investment of $200 million to support local commun |
|
| December 20, 2018 |
EXPRESS SCRIPTS HOLDING COMPANY dated as of December 20, 2018 TABLE OF CONTENTS ARTICLE I Exhibit 3.2 BY-LAWS of EXPRESS SCRIPTS HOLDING COMPANY dated as of December 20, 2018 TABLE OF CONTENTS ARTICLE I OFFICES SECTION 1. REGISTERED OFFICE 4 SECTION 2. OTHER OFFICES 4 ARTICLE II MEETINGS OF STOCKHOLDERS SECTION 1. ANNUAL MEETINGS 4 SECTION 2. SPECIAL MEETINGS 4 SECTION 3. VOTING 4 SECTION 4. QUORUM 5 SECTION 5. NOTICE OF MEETINGS 5 SECTION 6. ACTION WITHOUT MEETING 5 ARTICLE III DIRECT |
|
| December 20, 2018 |
ADDITIONAL GUARANTOR SUPPLEMENT December 20, 2018 Exhibit 4.2 EXECUTION VERSION ADDITIONAL GUARANTOR SUPPLEMENT December 20, 2018 JPMorgan Chase Bank, N.A., as Administrative Agent for the Banks party to the Revolving Credit and Letter of Credit Agreement dated as of April 6, 2018 and as amended as of November 15, 2018, among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), a Delaware corporation, Cigna Holding Company (formerly known |
|
| December 20, 2018 |
ADDITIONAL GUARANTOR SUPPLEMENT December 20, 2018 EX-4.3 6 ex43.htm EXHIBIT 4.3 Exhibit 4.3 EXECUTION VERSION ADDITIONAL GUARANTOR SUPPLEMENT December 20, 2018 Morgan Stanley Senior Funding, Inc., as Administrative Agent for the Banks party to the Term Loan Credit Agreement dated as of April 6, 2018, among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), a Delaware corporation, Cigna Holding Company (formerly known as Cigna Corporatio |
|
| December 20, 2018 |
Exhibit 4.6 EXECUTION VERSION SECOND SUPPLEMENTAL INDENTURE The Second Supplemental Indenture, dated as of December 20, 2018 (this “Second Supplemental Indenture”), among CIGNA CORPORATION (formerly known as Halfmoon Parent, Inc.) (the “Parent Guarantor”), a corporation organized and existing under the laws of the State of Delaware, MEDCO HEALTH SOLUTIONS, INC. (the “Company”), a corporation organ |
|
| December 20, 2018 |
TWENTY-FIFTH SUPPLEMENTAL INDENTURE Exhibit 4.4 EXECUTION VERSION TWENTY-FIFTH SUPPLEMENTAL INDENTURE The Twenty-Fifth Supplemental Indenture, dated as of December 20, 2018 (this “Twenty-Fifth Supplemental Indenture”), among CIGNA CORPORATION (formerly known as Halfmoon Parent Inc.) (the “Parent Guarantor”), a corporation organized and existing under the laws of the State of Delaware, EXPRESS SCRIPTS HOLDING COMPANY, a corporation o |
|
| December 20, 2018 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION EXPRESS SCRIPTS HOLDING COMPANY ARTICLE I Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF EXPRESS SCRIPTS HOLDING COMPANY ARTICLE I The name of the corporation is Express Scripts Holding Company (the “Corporation”). ARTICLE II The address, including street, number, city, and county, of the registered office of the Corporation in the State of Delaware is c/o The Corporation Trust Company, Corporation Trust Center, 1209 Ora |
|
| December 20, 2018 |
SUPPLEMENTAL INDENTURE IN RESPECT OF SUBSIDIARY GUARANTEES Exhibit 4.1 EXECUTION VERSION SUPPLEMENTAL INDENTURE IN RESPECT OF SUBSIDIARY GUARANTEES SUPPLEMENTAL INDENTURE No. 2, dated as of December 20, 2018 (this “Supplemental Indenture”), among CIGNA HOLDING COMPANY (formerly known as Cigna Corporation), a Delaware corporation and EXPRESS SCRIPTS HOLDING COMPANY, a Delaware corporation (each a “Guarantor” and together the “Guarantors”), CIGNA CORPORATIO |
|
| December 19, 2018 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): December 19, 2018 (December 18, 2018) EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdic |
|
| December 13, 2018 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): December 13, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction (Commission (I. |
|
| November 21, 2018 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): November 21, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction (Commissio |
|
| November 21, 2018 |
EX-2.1 Exhibit 2.1 November 21, 2018 Express Scripts Holding Company One Express Way St. Louis, Missouri 63121 Attention: Marty Akins, Senior Vice President and General Counsel Ladies and Gentlemen: Reference is made to the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018 (as it may be amended from time to time, the “Merger Agreement |
|
| October 31, 2018 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 31, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorpor |
|
| October 31, 2018 |
Express Scripts Announces 2018 Third Quarter Results EX-99.1 Exhibit 99.1 Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2018 Third Quarter Results ST. LOUIS, October 31, 2018 — Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 third quarter net income of $1,071.6 million or $1.89 per diluted share. Conso |
|
| October 31, 2018 |
ESRX / Express Scripts Holding Co. 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-35490 |
|
| September 18, 2018 |
U.S. DEPARTMENT OF JUSTICE GRANTS CLEARANCE TO CIGNA’S ACQUISITION OF EXPRESS SCRIPTS EX-99.1 Exhibit 99.1 U.S. DEPARTMENT OF JUSTICE GRANTS CLEARANCE TO CIGNA’S ACQUISITION OF EXPRESS SCRIPTS September 17, 2018 02:49 PM Eastern Daylight Time BLOOMFIELD, Conn. & ST. LOUIS — (BUSINESS WIRE) — Cigna Corporation (NYSE: CI) (“Cigna”) and Express Scripts Holding Company (NASDAQ: ESRX) (“Express Scripts”) today announced that the Antitrust Division of the United States Department of Just |
|
| September 18, 2018 |
Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): September 17, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of incorp |
|
| August 29, 2018 |
8-K 1 d519945d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 29, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdict |
|
| August 24, 2018 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): August 24, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of incorpora |
|
| August 24, 2018 |
Express Scripts Stockholders Approve Acquisition by Cigna EX-99.1 Exhibit 99.1 Express Scripts Stockholders Approve Acquisition by Cigna ST. LOUIS, Aug. 24, 2018 /PRNewswire/ – Stockholders of Express Scripts Holding Company (NASDAQ: ESRX) today approved the proposed acquisition of Express Scripts by Cigna. Based on a preliminary tabulation, approximately 78 percent of the shares of Express Scripts common stock outstanding and entitled to vote adopted th |
|
| August 16, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| August 15, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| August 13, 2018 |
Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 13, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorpora |
|
| August 13, 2018 |
EX-99.1 Exhibit 99.1 Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote “FOR” Merger Agreement with Cigna Press Release August 13, 2018 Express Scripts Reminds Stockholders to Vote “FOR” the Merger ST. LOUIS, Aug. 13, 2018 /PRNewswire/ — Express Scripts (NASDAQ: ESRX) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading independent p |
|
| August 13, 2018 |
EX-99.1 Exhibit 99.1 Leading Independent Proxy Advisory Firm Glass Lewis Recommends Express Scripts Stockholders Vote “FOR” Merger Agreement with Cigna Press Release August 13, 2018 Express Scripts Reminds Stockholders to Vote “FOR” the Merger ST. LOUIS, Aug. 13, 2018 /PRNewswire/ — Express Scripts (NASDAQ: ESRX) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading independent p |
|
| August 13, 2018 |
ESRX / Express Scripts Holding Co. FORM 8-K (Prospectus) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 13, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorpora |
|
| August 10, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| August 10, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| August 10, 2018 |
Leading Proxy Advisory Firm ISS Recommends Express Scripts Stockholders Vote “FOR” Merger with Cigna EX-99.1 Exhibit 99.1 Leading Proxy Advisory Firm ISS Recommends Express Scripts Stockholders Vote “FOR” Merger with Cigna ST. LOUIS, Aug. 10, 2018 / PRNewswire / Express Scripts (NASDAQ: ESRX) today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, has recommended that Express Scripts stockholders vote “FOR” Express Scripts’ merger agreement |
|
| August 10, 2018 |
Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 10, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation |
|
| August 10, 2018 |
Leading Proxy Advisory Firm ISS Recommends Express Scripts Stockholders Vote “FOR” Merger with Cigna EX-99.1 Exhibit 99.1 Leading Proxy Advisory Firm ISS Recommends Express Scripts Stockholders Vote “FOR” Merger with Cigna ST. LOUIS, Aug. 10, 2018 / PRNewswire / Express Scripts (NASDAQ: ESRX) today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, has recommended that Express Scripts stockholders vote “FOR” Express Scripts’ merger agreement |
|
| August 10, 2018 |
ESRX / Express Scripts Holding Co. 8-K (Prospectus) 425 1 d605208d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 10, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdict |
|
| August 10, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| August 9, 2018 |
ESRX / Express Scripts Holding Co. DEFA14A DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| August 8, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation o |
|
| August 8, 2018 |
EX-99.1 CIGNA REITERATES SUPPORT FOR PROPOSED MERGER WITH EXPRESS SCRIPTS August 2018 Exhibit 99.1 FORWARD LOOKING STATEMENTS Information included or incorporated by reference in this communication, and information which may be contained in other filings with the Securities and Exchange Commission (the “SEC”) and press releases or other public statements, contains or may contain forward-looking st |
|
| August 8, 2018 |
EX-99.1 CIGNA REITERATES SUPPORT FOR PROPOSED MERGER WITH EXPRESS SCRIPTS August 2018 Exhibit 99.1 FORWARD LOOKING STATEMENTS Information included or incorporated by reference in this communication, and information which may be contained in other filings with the Securities and Exchange Commission (the “SEC”) and press releases or other public statements, contains or may contain forward-looking st |
|
| August 8, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation o |
|
| August 3, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| August 3, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| August 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| August 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 1, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation o |
|
| August 1, 2018 |
EX-99.1 Exhibit 99.1 Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2018 Second Quarter Results - Reports 13% Consolidated GAAP Earnings Per Diluted Share Growth - Raises Core Adjusted EBITDA Guidance Range - Increases Client Retention Level - Projects 2% to 3% Core Adjusted Cl |
|
| August 1, 2018 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 1, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation o |
|
| August 1, 2018 |
EX-99.1 Exhibit 99.1 Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2018 Second Quarter Results - Reports 13% Consolidated GAAP Earnings Per Diluted Share Growth - Raises Core Adjusted EBITDA Guidance Range - Increases Client Retention Level - Projects 2% to 3% Core Adjusted Cl |
|
| August 1, 2018 |
ESRX / Express Scripts Holding Co. 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-35490 EXPRE |
|
| August 1, 2018 |
Exhibit 10.1 EXECUTIVE RETENTION AGREEMENT THIS RETENTION AGREEMENT (this “Agreement”), dated as of May 12, 2018, is by and between Cigna Corporation, a Delaware corporation (“Cigna”) and Timothy Wentworth (“Executive”). WHEREAS, Cigna and Executive are entering into this Agreement in connection with the proposed merger (the “Merger”) as contemplated by the Agreement and Plan of Merger, dated as o |
|
| July 30, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| July 27, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 1 d576961d425.htm 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. 001-35490 The following is a transcript of a video made available on www.makinghealthcaresimple.com. Your H |
|
| July 20, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| July 16, 2018 |
ESRX / Express Scripts Holding Co. DEFM14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of t |
|
| July 2, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 2, 2018 (June 27, 2018) EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of i |
|
| July 2, 2018 |
EX-2.1 Exhibit 2.1 EXECUTION VERSION AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER This Amendment No. 1 (this “Amendment”), dated as of June 27, 2018, to the Agreement and Plan of Merger (the “Merger Agreement”), dated as of March 8, 2018 (as amended, restated, modified or supplemented from time to time, the “Merger Agreement”), by and among Cigna Corporation (“Parent”), Express Scripts Holding |
|
| July 2, 2018 |
EX-2.1 Exhibit 2.1 EXECUTION VERSION AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER This Amendment No. 1 (this “Amendment”), dated as of June 27, 2018, to the Agreement and Plan of Merger (the “Merger Agreement”), dated as of March 8, 2018 (as amended, restated, modified or supplemented from time to time, the “Merger Agreement”), by and among Cigna Corporation (“Parent”), Express Scripts Holding |
|
| July 2, 2018 |
ESRX / Express Scripts Holding Co. 8-K (Prospectus) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 2, 2018 (June 27, 2018) EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of i |
|
| June 4, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 4, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 4, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 1 d574299d425.htm 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. 001-35490 The following information was made available on www.advancinghealthcare.com. Combining to deliver |
|
| June 4, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 4, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 1 d600052d425.htm 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. 001-35490 The following is a transcript of a video made available on www.advancinghealthcare.com. David Cor |
|
| June 4, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 4, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 4, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 4, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 1 d600037d425.htm 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. 001-35490 The following content was added to www.advancinghealthcare.com. Transcripts for new videos are fi |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| June 1, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| May 16, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| May 14, 2018 |
Submission of Matters to a Vote of Security Holders 8-K 1 d584437d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 10, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction |
|
| May 7, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| May 4, 2018 |
ESRX / Express Scripts Holding Co. PX14A6G PX14A6G 1 d54181px14a6g.htm NOTICE OF EXEMPT SOLICITATION Name of the registrant: Express Scripts Holding Company Name of person relying on exemption: New York State Comptroller Thomas P. DiNapoli, Trustee of the New York State Common Retirement Fund Address of person relying on exemption: Office of the New York State Comptroller Division of Legal Services 110 State Street, 14th Floor Albany, NY 1 |
|
| May 2, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| May 2, 2018 |
Express Scripts Announces 2018 First Quarter Results EX-99.1 Exhibit 99.1 Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2018 First Quarter Results ST. LOUIS, May 2, 2018 — Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share. Consolidated |
|
| May 2, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or Organ |
|
| May 2, 2018 |
Express Scripts Announces 2018 First Quarter Results EX-99.1 Exhibit 99.1 Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2018 First Quarter Results ST. LOUIS, May 2, 2018 — Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2018 first quarter net income of $623.2 million or $1.10 per diluted share. Consolidated |
|
| May 2, 2018 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 2, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or O |
|
| May 2, 2018 |
ESRX / Express Scripts Holding Co. PX14A6G PX14A6G 1 m52180px14a6g.htm NOTICE OF EXEMPT SOLICITATION Name of the registrant: Express Scripts Holding Company Name of person relying on exemption: New York State Comptroller Thomas P. DiNapoli, Trustee of the New York State Common Retirement Fund Address of person relying on exemption: Office of the New York State Comptroller Division of Legal Services 110 State Street, 14th Floor Albany, NY 1 |
|
| May 2, 2018 |
ESRX / Express Scripts Holding Co. 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-35490 EXPR |
|
| April 25, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 25, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of incorporation) (Com |
|
| April 25, 2018 |
EX-99.1 Express Scripts KEY FACTS FOR CIGNA INVESTORS Exhibit 99.1 FORWARD LOOKING STATEMENTS Information included or incorporated by reference in this communication, and information which may be contained in other filings with the Securities and Exchange Commission (the “SEC”) and press releases or other public statements, contains or may contain forward-looking statements. These forward-looking |
|
| April 25, 2018 |
EX-99.1 Express Scripts KEY FACTS FOR CIGNA INVESTORS Exhibit 99.1 FORWARD LOOKING STATEMENTS Information included or incorporated by reference in this communication, and information which may be contained in other filings with the Securities and Exchange Commission (the “SEC”) and press releases or other public statements, contains or may contain forward-looking statements. These forward-looking |
|
| April 25, 2018 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 25, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of incorporation) |
|
| April 24, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 23, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of incorporation) (Com |
|
| April 24, 2018 |
ESRX / Express Scripts Holding Co. 8-K (Prospectus) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): April 23, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of incorporation) |
|
| April 11, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| April 4, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 Designing personalized solutions Offering a full suite of medical, behavioral, pharmacy, specialty pharmacy and other health engagement services Optimizing care Leveraging technology and data to enhance care delivery and improve outcomes Creating value through collaboration Expanding value-based healthcare reimbursement models Important Information for Investors and Stockholders FORWARD LOOKING STATEMENTS Cautionary Notes on Forward Looking Statements Information included or incorporated by reference in this communication, and information which may be contained in other filings with the Securities and Exchange Commission (the “SEC”) and press releases or other public statements, contains or may contain forward-looking statements. |
|
| March 29, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| March 29, 2018 |
ESRX / Express Scripts Holding Co. DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (a |
|
| March 29, 2018 |
ESRX / Express Scripts Holding Co. DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the |
|
| March 19, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. |
|
| March 15, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 1 d530521d425.htm 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANY: EXPRESS SCRIPTS HOLDING COMPANY / CIGNA CORPORATION COMMISSION FILE NO. 001-35490 Express Scripts Holding Company posted the video of the CNBC interview held on March 8, 2018 on i |
|
| March 9, 2018 |
EX-3.1 Exhibit 3.1 AMENDMENT NO. 1 TO AMENDED AND RESTATED BYLAWS OF EXPRESS SCRIPTS HOLDING COMPANY Effective March 7, 2018, Express Scripts Holding Company amended its Amended and Restated Bylaws inserting the following as Section 6.11 thereof: Section 6.11. Forum for Adjudication of Certain Disputes. Unless the corporation consents in writing to the selection of an alternative forum (an “Altern |
|
| March 9, 2018 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 8, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction (Commission (I |
|
| March 9, 2018 |
EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among CIGNA CORPORATION, EXPRESS SCRIPTS HOLDING COMPANY, HALFMOON PARENT, INC., HALFMOON I, INC. and HALFMOON II, INC. Dated as of March 8, 2018 TABLE OF CONTENTS Page Article I THE MERGER Section 1.1 The Merger 2 Section 1.2 Closing 3 Section 1.3 Effective Time 3 Section 1.4 Effects of the Merger 3 Section 1.5 Constituent Documents 3 Section |
|
| March 9, 2018 |
EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among CIGNA CORPORATION, EXPRESS SCRIPTS HOLDING COMPANY, HALFMOON PARENT, INC., HALFMOON I, INC. and HALFMOON II, INC. Dated as of March 8, 2018 TABLE OF CONTENTS Page Article I THE MERGER Section 1.1 The Merger 2 Section 1.2 Closing 3 Section 1.3 Effective Time 3 Section 1.4 Effects of the Merger 3 Section 1.5 Constituent Documents 3 Section |
|
| March 9, 2018 |
Amendment No. 1 to Amended and Restated Bylaws of Express Scripts Holding Company. EX-3.1 Exhibit 3.1 AMENDMENT NO. 1 TO AMENDED AND RESTATED BYLAWS OF EXPRESS SCRIPTS HOLDING COMPANY Effective March 7, 2018, Express Scripts Holding Company amended its Amended and Restated Bylaws inserting the following as Section 6.11 thereof: Section 6.11. Forum for Adjudication of Certain Disputes. Unless the corporation consents in writing to the selection of an alternative forum (an “Altern |
|
| March 9, 2018 |
ESRX / Express Scripts Holding Co. FORM 8-K (Prospectus) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 8, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction (Commission (I |
|
| March 9, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANIES: EXPRESS SCRIPTS HOLDING COMPANY AND CIGNA CORPORATION COMMISSION FILE NO. |
|
| March 9, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANIES: EXPRESS SCRIPTS HOLDING COMPANY AND CIGNA CORPORATION COMMISSION FILE NO. |
|
| March 9, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) 425 FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANIES: EXPRESS SCRIPTS HOLDING COMPANY AND CIGNA CORPORATION COMMISSION FILE NO. |
|
| March 9, 2018 |
ESRX / Express Scripts Holding Co. 425 (Prospectus) FILED BY EXPRESS SCRIPTS HOLDING COMPANY PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 AND DEEMED FILED PURSUANT TO RULE 14a-12 UNDER THE SECURITIES EXCHANGE ACT OF 1934 SUBJECT COMPANIES: EXPRESS SCRIPTS HOLDING COMPANY AND CIGNA CORPORATION COMMISSION FILE NO. |
|
| March 8, 2018 |
ESRX / Express Scripts Holding Co. 8-K (Prospectus) 425 1 d549178d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 8, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdictio |
|
| March 8, 2018 |
CIGNA TO ACQUIRE EXPRESS SCRIPTS FOR $67 BILLION EX-99.1 Exhibit 99.1 CIGNA TO ACQUIRE EXPRESS SCRIPTS FOR $67 BILLION • Drives greater affordability and connectivity with customers and their health care providers, while making health care simpler • Creates an expanded portfolio of health services with greater choice, alignment and value across a proven services platform • Expands distribution of health services for employers, health plans and g |
|
| March 8, 2018 |
CIGNA TO ACQUIRE EXPRESS SCRIPTS FOR $67 BILLION EX-99.1 2 d549178dex991.htm EX-99.1 Exhibit 99.1 CIGNA TO ACQUIRE EXPRESS SCRIPTS FOR $67 BILLION • Drives greater affordability and connectivity with customers and their health care providers, while making health care simpler • Creates an expanded portfolio of health services with greater choice, alignment and value across a proven services platform • Expands distribution of health services for e |
|
| March 8, 2018 |
ESRX / Express Scripts Holding Co. 8-K (Current Report) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): March 8, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of incorporation) ( |
|
| February 27, 2018 |
Express Scripts Announces 2017 Fourth Quarter and Full Year Results EX-99.1 Exhibit 99.1 Contact: Jim Havel, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2017 Fourth Quarter and Full Year Results ST. LOUIS, February 27, 2018 ? Express Scripts Holding Company (Nasdaq: ESRX) announced consolidated 2017 fourth quarter and full year net income of $2,327.6 million an |
|
| February 27, 2018 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporatio |
|
| February 27, 2018 |
Subsidiaries of Express Scripts Holding Company. EXHIBIT 21.1 The following are subsidiaries of the Company as of December 31, 2017. The names of other subsidiaries have been omitted as they would not, if considered in the aggregate as a single subsidiary, constitute a significant subsidiary pursuant to Item 601(b)(21)(ii) of Regulation S-K under the Securities Exchange Act of 1934, as amended. Subsidiary State of Organization D/B/A Accredo Heal |
|
| February 27, 2018 |
ESRX / Express Scripts Holding Co. 10-K (Annual Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2017, OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number: 1-35490 EXPRES |
|
| February 27, 2018 |
Statement regarding computation of ratio of earnings to fixed charges. EXHIBIT 12.1 EXPRESS SCRIPTS HOLDING COMPANY Calculation of Ratio of Earnings to Fixed Charges (Dollar amounts in millions) Year Ended December 31, 2017 2016 2015 2014 2013 Income from continuing operations before income taxes(1) $ 4,921.9 $ 4,421.5 $ 3,859.6 $ 3,056.1 $ 3,012.0 Add: Interest expense(2) 590.2 552.1 498.7 511.4 529.1 Estimated interest component of rental expense 20.2 21.0 20.8 19. |
|
| February 13, 2018 |
ESRX / Express Scripts Holding Co. / DODGE & COX - SCHEDULE 13G Passive Investment SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 0)* EXPRESS SCRIPTS HOLDING COMPANY (Name of Issuer) Common Stock (Title of Class of Securities) 30219G108 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule p |
|
| February 9, 2018 |
ESRX / Express Scripts Holding Co. / VANGUARD GROUP INC Passive Investment expressscriptsholdingco.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3 )* Name of issuer: Express Scripts Holding Co Title of Class of Securities: Common Stock CUSIP Number: 30219G108 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the a |
|
| January 26, 2018 |
8-K 1 d523000d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 24, 2018 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jur |
|
| December 19, 2017 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 13, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| December 19, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 13, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| December 19, 2017 |
Exhibit 99.1 EVICORE CLOSE PRESS RELEASE EXPRESS SCRIPTS CLOSES ACQUISITION OF EVICORE; COMPANIES UNITE TO IMPROVE HEALTHCARE FOR 100 MILLION AMERICANS ? Improves ability to address enormous inefficiencies and unnecessary spending ? Leverages evidence-based medicine, advanced data analytics and clinical specialization to improve care and control cost across pharmacy and medical platforms ? Deliver |
|
| November 30, 2017 |
Exhibit 4.2 EXECUTION VERSION TWENTY-THIRD SUPPLEMENTAL INDENTURE Dated as of November 30, 2017 Supplementing that Certain INDENTURE Dated as of November 21, 2011 Among EXPRESS SCRIPTS HOLDING COMPANY THE GUARANTORS PARTY HERETO and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee and Calculation Agent FLOATING RATE SENIOR NOTES DUE 2020 This Twenty-Third Supplemental Indenture, dated as of Nove |
|
| November 30, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 30, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| November 30, 2017 |
Exhibit 4.3 EXECUTION VERSION TWENTY-FOURTH SUPPLEMENTAL INDENTURE Dated as of November 30, 2017 Supplementing that Certain INDENTURE Dated as of November 21, 2011 Among EXPRESS SCRIPTS HOLDING COMPANY THE GUARANTORS PARTY HERETO and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee 3.050% SENIOR NOTES DUE 2022 This Twenty-Fourth Supplemental Indenture, dated as of November 30, 2017 (this ?Twenty |
|
| November 30, 2017 |
Exhibit 4.1 EXECUTION VERSION TWENTY-SECOND SUPPLEMENTAL INDENTURE Dated as of November 30, 2017 Supplementing that Certain INDENTURE Dated as of November 21, 2011 Among EXPRESS SCRIPTS HOLDING COMPANY THE GUARANTORS PARTY HERETO and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee 2.600% SENIOR NOTES DUE 2020 This Twenty-Second Supplemental Indenture, dated as of November 30, 2017 (this ?Twenty |
|
| November 22, 2017 |
Exhibit 1.1 EXECUTION VERSION EXPRESS SCRIPTS HOLDING COMPANY $500,000,000 2.600% Senior Notes Due 2020 $400,000,000 Floating Rate Senior Notes Due 2020 $500,000,000 3.050% Senior Notes Due 2022 UNDERWRITING AGREEMENT November 20, 2017 MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED One Bryant Park New York, New York 10036 CITIGROUP GLOBAL MARKETS INC., 388 Greenwich Street New York, New York 1 |
|
| November 22, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 20, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| November 22, 2017 |
Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-221565 CALCULATION OF REGISTRATION FEE Title of each Class of Securities to be Registered Proposed Maximum Aggregate Offering Price Amount of Registration Fee(1) 2.600 % Senior Notes due 2020 Floating Rate Senior Notes due 2020 3.050 % Senior Notes due 2022 $1,400,000,000 $174,300 (1) The filing fee is calculated in accordance |
|
| November 20, 2017 |
Filed Pursuant to Rule 433 Registration Statement No. 333-221565 Pricing Term Sheet November 20, 2017 Express Scripts Holding Company $500,000,000 2.600% Senior Notes due 2020 $400,000,000 Floating Rate Senior Notes due 2020 $500,000,000 3.050% Senior Notes due 2022 This pricing term sheet to the preliminary prospectus supplement dated November 20, 2017 should be read together with the preliminary |
|
| November 20, 2017 |
SUBJECT TO COMPLETION, DATED NOVEMBER 20, 2017 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-221565 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and they are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not pe |
|
| November 14, 2017 |
Statement re: Computation of Ratio of Earnings to Fixed Charges. EX-12.1 EXHIBIT 12.1 EXPRESS SCRIPTS HOLDING COMPANY Calculation of Ratio of Earnings to Fixed Charges (Dollar amounts in millions) Nine Months Ended September 30, Year Ended December 31, 2017 2016 2016 2015 2014 2013 2012 Income from continuing operations before income taxes(1) $ 3,493.2 $ 3,084.5 $ 4,421.5 $ 3,859.6 $ 3,056.1 $ 3,012.0 $ 2,188.5 Add: Interest expense(2) 439.9 406.1 552.1 498.7 5 |
|
| November 14, 2017 |
Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ? CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) WELLS FARGO BANK, NATIONAL ASSOCIATION (Exact name of trustee as specified in its charter) A National |
|
| November 14, 2017 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 14, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| November 14, 2017 |
Power of Attorney (included on signature pages hereto). Table of Contents As filed with the Securities and Exchange Commission on November 14, 2017 Registration No. |
|
| November 14, 2017 |
EXPRESS SCRIPTS HOLDING COMPANY Unaudited Consolidated Balance Sheet Exhibit 99.2 This Exhibit to the Current Report on Form 8-K of Express Scripts Holding Company (the ?Company) includes Item 1 of the Company?s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (?SEC?) on October 24, 2017, with amendments to Note 12 - Condensed consolidating financial information. On October 26, 2017, the Company entered into an Amendment and Restateme |
|
| November 14, 2017 |
EXPRESS SCRIPTS HOLDING COMPANY CONSOLIDATED BALANCE SHEET Exhibit 99.1 This Exhibit to the Current Report on Form 8-K of Express Scripts Holding Company (the ?Company?) includes Item 8 of the Company?s Annual Report on Form 10-K for the year ended December 31, 2016 filed with the Securities and Exchange Commission (?SEC?) on February 14, 2017, with amendments to Note 12 - Condensed consolidating financial information. On October 26, 2017, the Company ent |
|
| November 3, 2017 |
Exhibit 10.1 TRANSITION AND RELEASE AGREEMENT ERIC SLUSSER I. Introduction. I, the undersigned, am currently an employee of Express Scripts Holding Company (?Express Scripts? or ?Company?) and/or an officer or employee of one or more of its subsidiaries or predecessor or affiliated companies, and prior to October 25, 2017 served as Executive Vice President and Chief Financial Officer of the Compan |
|
| November 3, 2017 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 30, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorpor |
|
| October 31, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 26, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| October 31, 2017 |
Exhibit 10.2 Commercial Paper Dealer Agreement 4(a)(2) Program Between: EXPRESS SCRIPTS HOLDING COMPANY, as Issuer and [ ], as Dealer Concerning Notes to be issued pursuant to an Issuing and Paying Agent Agreement, dated as of hereof, between the Issuer and [ ], as Issuing and Paying Agent Dated as of October 27, 2017 Commercial Paper Dealer Agreement 4(a)(2) Program This COMMERCIAL PAPER DEALER A |
|
| October 31, 2017 |
Exhibit 10.1 AMENDMENT AND RESTATEMENT AGREEMENT dated as of October 26, 2017 (this ?Agreement?), among EXPRESS SCRIPTS HOLDING COMPANY, a Delaware corporation (?Company?), the SUBSIDIARY GUARANTORS party hereto, the LENDERS party hereto, CITIBANK N.A. (?Citibank?), in its capacity as successor administrative agent (the ?Administrative Agent?), and CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH (?Credit |
|
| October 24, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017. ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-35490 |
|
| October 24, 2017 |
Express Scripts Announces 2017 Third Quarter Results EX-99.1 2 d482232dex991.htm EX-99.1 Exhibit 99.1 Contact: Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2017 Third Quarter Results ST. LOUIS, October 24, 2017 – Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 third quarter net income of $841.7 million or $1.46 per diluted share. 2017 third quarter adjusted |
|
| October 24, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 18, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| October 24, 2017 |
Express Scripts Appoints James M. Havel Chief Financial Officer Exhibit 99.2 Express Scripts Appoints James M. Havel Chief Financial Officer ST. LOUIS, (Oct. 24, 2017) ? Express Scripts Holding Company (NASDAQ: ESRX) today announced that James M. Havel, who previously served as Express Scripts? Executive Vice President, has been named Executive Vice President and Chief Financial Officer, effective October 25, 2017. Eric Slusser, Executive Vice President and Ch |
|
| October 12, 2017 |
October 12, 2017 VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N. |
|
| October 10, 2017 |
Exhibit 99.1 Express Scripts to Acquire eviCore healthcare; Accelerates Company?s Shift to Patient Benefit Management ? Improves ability to address $1 trillion annually wasted on unnecessary healthcare spending ? Establishes cornerstone platform to rapidly advance into Medical Benefits Management Services, a large and growing market ? Creates a comprehensive suite of data-driven service solutions |
|
| October 10, 2017 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 9, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or O |
|
| August 30, 2017 |
Confidential Treatment Requested by Express Scripts Holding Company under 17 C.F.R. § 200.83 Confidential Treatment Requested by Express Scripts Holding Company under 17 C.F.R. ? 200.83 August 30, 2017 FOIA Confidential Treatment Request The entity requesting confidential treatment is: Express Scripts Holding Company One Express Way, St. Louis, MO 63121 CERTAIN PORTIONS OF THIS LETTER AS SUBMITTED VIA EDGAR HAVE BEEN OMITTED AND PROVIDED SEPARATELY TO THE COMMISSION UNDER A SEPARATE COVER |
|
| August 10, 2017 |
[BRYAN CAVE LETTERHEAD] August 10, 2017 VIA EDGAR Joel Parker Senior Assistant Chief Accountant Office of Beverages, Apparel and Mining Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| July 25, 2017 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 25, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| July 25, 2017 |
Express Scripts Announces 2017 Second Quarter Results Exhibit 99.1 Contact: Eric Slusser, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2017 Second Quarter Results ST. LOUIS, July 25, 2017 ? Express Scripts Holding Company (Nasdaq: ESRX) announced 2017 second quarter net income of $801.8 million or $1.37 per diluted share. 2017 second quarter adjust |
|
| July 25, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017. ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-35490 EXPRE |
|
| June 27, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 27, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or Org |
|
| June 26, 2017 |
June 26, 2017 VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N. |
|
| June 20, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 20, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or Org |
|
| June 5, 2017 |
[BRYAN CAVE LETTERHEAD] June 5, 2017 VIA EDGAR Joel Parker Senior Assistant Chief Accountant Office of Beverages, Apparel and Mining Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| May 23, 2017 |
8-K 1 d397394d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 19, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction |
|
| May 12, 2017 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 11, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| April 24, 2017 |
Exhibit 99.1 Contact: Eric Slusser, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2017 First Quarter Results; Provides Update on Anthem Relationship and Visibility into Core PBM Business Excluding Contribution from Anthem, Coventry and Catamaran ST. LOUIS, April 24, 2017 ? Express Scripts Holding |
|
| April 24, 2017 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 24, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporat |
|
| April 24, 2017 |
ESRX / Express Scripts Holding Co. 10-Q - Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017. ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-35490 EXPR |
|
| March 17, 2017 |
DEF 14A 1 d331565ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Stat |
|
| March 17, 2017 |
DEFA14A 1 d331565ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confident |
|
| March 8, 2017 |
Exhibit 10.1 FORM OF EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the ?Agreement?) is made and entered on the date specified on the signature page hereto, effective as of [ ] (the ?Effective Date?), by and between Express Scripts Holding Company, a Delaware corporation (?ESHC?), and [ ] (?Executive?). WHEREAS, the parties wish to enter into this Agreement to set forth the te |
|
| March 8, 2017 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 8, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| February 14, 2017 |
Express Scripts Holding 10-K (Annual Report) Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 14, 2017 |
Exhibit 24 SECTION 16 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Martin P. |
|
| February 14, 2017 |
Express Scripts Announces 2016 Fourth Quarter and Full Year Results EX-99.1 Exhibit 99.1 Contact: Eric Slusser, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2016 Fourth Quarter and Full Year Results ST. LOUIS, February 14, 2017 ? Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 fourth quarter and full year net income of $1,434.7 million and $3,404.4 |
|
| February 14, 2017 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 14, 2017 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorpo |
|
| February 14, 2017 |
Exhibit 24 SECTION 16 POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Martin P. |
|
| February 14, 2017 |
EXHIBIT 21.1 The following are subsidiaries of the Company as of December 31, 2016. The names of other subsidiaries have been omitted as they would not, if considered in the aggregate as a single subsidiary, constitute a significant subsidiary pursuant to Item 601(b)(21)(ii) of Regulation S-K under the Securities Exchange Act of 1934, as amended. Subsidiary State of Organization D/B/A Accredo Heal |
|
| February 14, 2017 |
EXHIBIT 12.1 EXPRESS SCRIPTS HOLDING COMPANY Calculation of Ratio of Earnings to Fixed Charges (Dollar amounts in millions) Year Ended December 31, 2016 2015 2014 2013 2012 Income from continuing operations before income taxes(1) $ 4,421.5 $ 3,859.6 $ 3,056.1 $ 3,012.0 $ 2,188.5 Add: Interest expense(2) 552.1 498.7 511.4 529.1 619.0 Estimated interest component of rental expense 21.0 20.8 19.9 20. |
|
| February 10, 2017 |
Express Scripts Holding 3G/A (Passive Acquisition of More Than 5% of Shares) SC 13G/A 1 expressscriptsholdingco.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: Express Scripts Holding Co Title of Class of Securities: Common Stock CUSIP Number: 30219G108 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box to designate the r |
|
| December 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 16, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| December 14, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 14, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporatio |
|
| December 14, 2016 |
Express Scripts Holding Company Announces 2017 Financial Guidance EX-99.1 Exhibit 99.1 Contact: Eric Slusser, Chief Financial Officer Ben Bier, Vice President Investor Relations (314) 810-3115 [email protected] Express Scripts Holding Company Announces 2017 Financial Guidance ST. LOUIS, December 14, 2016?Express Scripts Holding Company (Nasdaq: ESRX) anticipates achieving adjusted earnings per diluted share1 for 2017 in the range of $6.82 to |
|
| October 28, 2016 |
Express Scripts Holding FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 28, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorpor |
|
| October 25, 2016 |
Express Scripts Holding 10-Q (Quarterly Report) Document Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| October 25, 2016 |
Express Scripts Announces 2016 Third Quarter Results EX-99.1 Exhibit 99.1 Contact: Eric Slusser, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2016 Third Quarter Results ST. LOUIS, October 25, 2016 ? Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 third quarter net income of $722.9 million, or $1.15 per diluted share. 2016 third quart |
|
| October 25, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 25, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| July 28, 2016 |
Express Scripts Announces Final Results of Maximum Tender Offers EX-99.1 Exhibit 99.1 Express Scripts Announces Final Results of Maximum Tender Offers ST. LOUIS, July 28, 2016 ? Express Scripts Holding Company (NASDAQ: ESRX) (the ?Company? or ?Express Scripts?) today announced the final tender results for its previously announced tender offers (the ?Maximum Tender Offers?) to purchase for cash up to an aggregate principal amount of the debt securities listed in |
|
| July 28, 2016 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 28, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or Org |
|
| July 25, 2016 |
Express Scripts Holding 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 . ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 1-35490 EXPR |
|
| July 25, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 25, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or Org |
|
| July 25, 2016 |
EX-99.1 Exhibit 99.1 Contact: Eric Slusser, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2016 Second Quarter Results; Narrows 2016 Full-Year Adjusted Diluted EPS Guidance Range; Raises Mid-Point; Provides 2016 Third Quarter Guidance ST. LOUIS, July 25, 2016 ? Express Scripts Holding Company (Nas |
|
| July 15, 2016 |
Express Scripts Announces Early Tender Results and Upsizing of Maximum Tender Offers EX-99.1 Exhibit 99.1 Express Scripts Announces Early Tender Results and Upsizing of Maximum Tender Offers ST. LOUIS, July 14, 2016 ? Express Scripts Holding Company (NASDAQ: ESRX) (the ?Company? or ?Express Scripts?) today announced the early tender results for its previously announced tender offers (the ?Maximum Tender Offers?) to purchase for cash up to an aggregate principal amount of the debt |
|
| July 15, 2016 |
Express Scripts Holding 8-K (Current Report/Significant Event) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 14, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| July 15, 2016 |
Express Scripts Announces Pricing of Maximum Tender Offers EX-99.2 Exhibit 99.2 Express Scripts Announces Pricing of Maximum Tender Offers ST. LOUIS, July 14, 2016 ? Express Scripts Holding Company (NASDAQ: ESRX) (the ?Company? or ?Express Scripts?) today announced the consideration payable in connection with its previously announced tender offers (the ?Maximum Tender Offers?) to purchase for cash up to an aggregate principal amount of the debt securities |
|
| July 7, 2016 |
Express Scripts Announces Pricing and Expiration of Any and All Tender Offer EX-99.1 Exhibit 99.1 Express Scripts Announces Pricing and Expiration of Any and All Tender Offer ST. LOUIS, July 6, 2016 ? Express Scripts Holding Company (NASDAQ: ESRX) (the ?Company? or ?Express Scripts?) today announced the pricing and expiration of its previously announced tender offer (the ?Tender Offer?) to purchase for cash any and all of its outstanding 2.650% senior notes due 2017 (the ? |
|
| July 7, 2016 |
Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 6, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporatio |
|
| July 5, 2016 |
EX-4.1 Exhibit 4.1 EIGHTEENTH SUPPLEMENTAL INDENTURE Dated as of July 5, 2016 Supplementing that Certain INDENTURE Dated as of November 21, 2011 Among EXPRESS SCRIPTS HOLDING COMPANY THE GUARANTORS PARTY HERETO and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee 3.000% SENIOR NOTES DUE 2023 This Eighteenth Supplemental Indenture, dated as of July 5, 2016 (this ?Eighteenth Supplemental Indenture |
|
| July 5, 2016 |
EX-4.2 Exhibit 4.2 NINETEENTH SUPPLEMENTAL INDENTURE Dated as of July 5, 2016 Supplementing that Certain INDENTURE Dated as of November 21, 2011 Among EXPRESS SCRIPTS HOLDING COMPANY THE GUARANTORS PARTY HERETO and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee 3.400% SENIOR NOTES DUE 2027 This Nineteenth Supplemental Indenture, dated as of July 5, 2016 (this ?Nineteenth Supplemental Indenture |
|
| July 5, 2016 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 5, 2016 (June 29, 2016) EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of I |
|
| July 5, 2016 |
EX-4.3 Exhibit 4.3 TWENTIETH SUPPLEMENTAL INDENTURE Dated as of July 5, 2016 Supplementing that Certain INDENTURE Dated as of November 21, 2011 Among EXPRESS SCRIPTS HOLDING COMPANY THE GUARANTORS PARTY HERETO and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee 4.800% SENIOR NOTES DUE 2046 This Twentieth Supplemental Indenture, dated as of July 5, 2016 (this ?Twentieth Supplemental Indenture?), |
|
| July 5, 2016 |
EX-1.1 Exhibit 1.1 Execution Version EXPRESS SCRIPTS HOLDING COMPANY $1,000,000,000 3.000% Senior Notes Due 2023 $1,500,000,000 3.400% Senior Notes Due 2027 $1,500,000,000 4.800% Senior Notes Due 2046 UNDERWRITING AGREEMENT June 29, 2016 CITIGROUP GLOBAL MARKETS INC., 388 Greenwich Street New York, New York 10013 CREDIT SUISSE SECURITIES (USA) LLC, Eleven Madison Avenue New York, New York 10010-36 |
|
| June 30, 2016 |
424B5 1 d208258d424b5.htm 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-196442 CALCULATION OF REGISTRATION FEE Title of each Class of Securities to be Registered Proposed Maximum Aggregate Offering Price Amount of Registration Fee(1) 3.000% Senior Notes due 2023 3.400% Senior Notes due 2027 4.800% Senior Notes due 2046 $4,000,000,000 $402,800 (1) The filing fee is c |
|
| June 29, 2016 |
Express Scripts Announces Tender Offers for Outstanding Debt Securities EX-99.1 Exhibit 99.1 Express Scripts Announces Tender Offers for Outstanding Debt Securities ST. LOUIS, June 29, 2016 ? Express Scripts Holding Company (NASDAQ: ESRX) (the ?Company? or ?Express Scripts?) today announced that it has commenced tender offers to purchase for cash the debt securities listed in the tables below (collectively, the ?Securities? and each a ?series?). Any and All of the Out |
|
| June 29, 2016 |
Express Scripts Holding FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 29, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporati |
|
| June 29, 2016 |
SUBJECT TO COMPLETION, DATED JUNE 29, 2016 424B5 1 d208258d424b5.htm 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-196442 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and they are not soliciting an offer to buy these securities in any jurisdiction w |
|
| June 29, 2016 |
Filed Pursuant to Rule 433 Registration Statement No. 333-196442 Pricing Term Sheet June 29, 2016 Express Scripts Holding Company $1,000,000,000 3.000% Senior Notes due 2023 $1,500,000,000 3.400% Senior Notes due 2027 $1,500,000,000 4.800% Senior Notes due 2046 This pricing term sheet to the preliminary prospectus supplement dated June 29, 2016 should be read together with the preliminary prospect |
|
| May 20, 2016 |
Express Scripts Holding FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 20, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporatio |
|
| May 4, 2016 |
S-8 As filed with the U.S. Securities and Exchange Commission on May 4, 2016 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 45-2884094 (State or other jurisdiction of incorporation or organiza |
|
| May 4, 2016 |
EX-10.5 Exhibit 10.5 [EXPRESS SCRIPTS HOLDING COMPANY] RESTRICTED STOCK UNIT GRANT NOTICE Notice is hereby given of the following award of Restricted Stock Units (the ?Award?), which entitles the Grantee to receive one share of the common stock, $0.01 par value per share, of Express Scripts Holding Company (?Common Stock?) for each Restricted Stock Unit pursuant to the following terms and conditio |
|
| May 4, 2016 |
FORM OF EXECUTIVE EMPLOYMENT AGREEMENT EX-10.2 Exhibit 10.2 FORM OF EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the ?Agreement?) is made and entered on the date specified on the signature page hereto, effective as of [ ] (the ?Effective Date?), by and between Express Scripts Holding Company, a Delaware corporation (?ESHC?), and [ ] (?Executive?). WHEREAS, the parties wish to enter into this Agreement to set fort |
|
| May 4, 2016 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 4, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or O |
|
| May 4, 2016 |
EX-10.7 Exhibit 10.7 [EXPRESS SCRIPTS HOLDING COMPANY] STOCK OPTION GRANT NOTICE Notice is hereby given of the following option grant (the ?Option?) to purchase shares of common stock, $0.01 par value per share, of Express Scripts Holding Company (the ?Common Stock?) pursuant to the following terms and conditions: ? Optionee: ? Grant Date: ? Exercise Price Per Share: ? Number of Option Shares: ? T |
|
| May 4, 2016 |
EX-10.6 Exhibit 10.6 [EXPRESS SCRIPTS HOLDING COMPANY] PERFORMANCE SHARE AWARD GRANT NOTICE Notice is hereby given of the following award of Performance Shares (the ?Award?) for shares of the common stock, $0.01 par value per share, of Express Scripts Holding Company (the ?Common Stock?) pursuant to the following terms and conditions: ? Grantee: ? Grant Date: ? Target Grant: ? Performance Period: |
|
| May 4, 2016 |
EX-10.3 Exhibit 10.3 [EXPRESS SCRIPTS HOLDING COMPANY] RESTRICTED STOCK UNIT GRANT NOTICE FOR NON-EMPLOYEE DIRECTORS Notice is hereby given of the following award of Restricted Stock Units (the ?Award?), which entitles the Grantee to receive one share of the common stock, $0.01 par value per share (?Common Stock?), of Express Scripts Holding Company (the ?Company?) for each Restricted Stock Unit p |
|
| May 4, 2016 |
EX-10.1 Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the ?Agreement?) is made and entered on the date specified on the signature page hereto, effective as of May 4, 2016 (the ?Effective Date?), by and between Express Scripts Holding Company, a Delaware corporation (?ESHC?), and Timothy Wentworth (?Executive?). WHEREAS, the parties wish to enter into this Agreeme |
|
| May 4, 2016 |
EX-10.4 Exhibit 10.4 [EXPRESS SCRIPTS HOLDING COMPANY] STOCK OPTION GRANT NOTICE FOR NON-EMPLOYEE DIRECTORS Notice is hereby given of the following option grant (the ?Option?) to purchase shares of common stock, $0.01 par value per share, of Express Scripts Holding Company (the ?Company?) pursuant to the following terms and conditions: ? Optionee: ? Grant Date: ? Exercise Price Per Share: $ ? Numb |
|
| April 25, 2016 |
Express Scripts Holding 10-Q (Quarterly Report) 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| April 25, 2016 |
Express Scripts Holding FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 25, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporat |
|
| April 25, 2016 |
EX-99.1 Exhibit 99.1 Contact: Eric Slusser, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces 2016 First Quarter Results; Increases 2016 Guidance Range: Raises Mid-Point; Provides 2016 Second Quarter Guidance ST. LOUIS, April 25, 2016 ? Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 fi |
|
| April 19, 2016 |
Express Scripts Holding FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 19, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporat |
|
| March 21, 2016 |
Express Scripts Holding DEFA14A DEFA14A 1 d70696ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidenti |
|
| March 21, 2016 |
Express Scripts Holding Company 2016 Long-Term Incentive Plan (the “ESRX LTIP”) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the |
|
| March 10, 2016 |
8-K 1 d144839d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 9, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) Delaware 001-35490 45-2884094 (State or Other Jurisd |
|
| March 10, 2016 |
EX-3.1 Exhibit 3.1 AMENDED AND RESTATED BYLAWS of EXPRESS SCRIPTS HOLDING COMPANY As amended on March 9, 2016 1. MEETINGS OF STOCKHOLDERS. 1.1 Annual Meeting. The annual meeting of stockholders shall be held on the date and at the time fixed from time to time by the board of directors (the ?Board?), provided, that each successive annual meeting shall be held on the fourth Wednesday in May of each |
|
| February 27, 2016 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 26, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jurisdiction of Incorporation or |
|
| February 27, 2016 |
Express Scripts Announces Pricing and Expiration of Tender Offer EX-99.1 Exhibit 99.1 Contact: Eric Slusser, Chief Financial Officer Ben Bier, Vice President, Investor Relations (314) 810-3115 [email protected] Express Scripts Announces Pricing and Expiration of Tender Offer ST. LOUIS, MO (February 26, 2016) ? Express Scripts Holding Company (NASDAQ: ESRX) (the ?Company? or ?Express Scripts?) today announced the pricing and expiration of it |
|
| February 26, 2016 |
Capped Accelerated Share Repurchase Transaction EX-10.1 2 d150995dex101.htm EX-10.1 EXHIBIT 10.1 EXECUTION COPY Morgan Stanley & Co. LLC 1585 Broadway New York, NY 10036-8293 Attn: Joshua Birbach Telephone: 212-761-1719 Facsimile: 212-507-8717 February 25, 2016 Capped Accelerated Share Repurchase Transaction Express Scripts Holding Company One Express Way St. Louis, MO 63121 Attention: Timothy Smith Telephone: 314-684-5759 Dear Sir/Madam: The p |
|
| February 26, 2016 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 26, 2016 (February 25, 2016) EXPRESS SCRIPTS HOLDING COMPANY (Exact Name of Registrant as Specified in its Charter) DELAWARE 001-35490 45-2884094 (State or Other Jur |
|
| February 25, 2016 |
EX-1.1 Exhibit 1.1 EXECUTION VERSION EXPRESS SCRIPTS HOLDING COMPANY $500,000,000 3.300% Senior Notes Due 2021 $1,500,000,000 4.500% Senior Notes Due 2026 UNDERWRITING AGREEMENT February 22, 2016 CITIGROUP GLOBAL MARKETS INC., 388 Greenwich Street, New York, New York 10013 CREDIT SUISSE SECURITIES (USA) LLC, Eleven Madison Avenue, New York, New York 10010-3629 MORGAN STANLEY & CO. LLC 1585 Broadwa |
|
| February 25, 2016 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 25, 2016 EXPRESS SCRIPTS HOLDING COMPANY (Exact name of registrant as specified in its charter) Delaware 001-35490 45-2884094 (State or other jurisdiction of incorpo |
